Efficacy and safety of the new drug against multiple sclerosis «PEGylated Interferon beta-1a Human» in monkeys compared with unmodified interferon beta-1a

The article presents the results of studies on the safety and efficacy of long-acting drug for the treatment of multiple sclerosis on the basis of recombinant human interferon beta-1a «PEGylated interferon beta-1a Human» (PEG IFN beta-1a) in monkeys Macaca mulatta in subcutaneous and intramuscular i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: N. A. Spirina, Ja. Ju. Ustjugov, A. A. Aleksandrov, M. V. Artjuhova, A. B. Dzhelija
Formato: Artigo
Idioma:Russo
Publicado em: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Colecção:Биопрепараты: Профилактика, диагностика, лечение
Assuntos:
интерферон бета-1а
пегилированный интерферон бета-1а
рассеянный склероз
фармакодинамика
безопасность
эффективность
токсичность
interferon beta-1a
pegylated interferon beta-1a
multiple sclerosis
pharmacodynamics
safety
efficiency
toxicity
Acesso em linha:https://www.biopreparations.ru/jour/article/view/50
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados